Corcept Therapeutics
CORT
#2296
Rank
โ‚น771.17 B
Marketcap
โ‚น7,046
Share price
3.10%
Change (1 day)
5.31%
Change (1 year)

EPS for Corcept Therapeutics (CORT)

EPS in 2023 (TTM): โ‚น72.68

According to Corcept Therapeutics 's latest financial reports the company's current EPS (TTM) is โ‚น48.84. In 2022 the company made an earnings per share (EPS) of โ‚น89.22 a decrease over its 2021 EPS that were of โ‚น91.10.

EPS history for Corcept Therapeutics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น72.68-18.55%
2022โ‚น89.22-2.06%
2021โ‚น91.105.43%
2020โ‚น86.4110.84%
2019โ‚น77.9527.69%
2018โ‚น61.05-42.48%
2017โ‚น106.131518.29%
2016โ‚น6.56-199.75%
2015-โ‚น6.57-77.42%
2014-โ‚น29.12-32.61%
2013-โ‚น43.2012.2%
2012-โ‚น38.512.5%
2011-โ‚น37.572.56%
2010-โ‚น36.632.63%
2009-โ‚น35.69-11.63%
2008-โ‚น40.3926.47%
2007-โ‚น31.93-68.81%
2006-โ‚น102.3723.86%
2005-โ‚น82.65-1.12%
2004-โ‚น83.59-27.05%
2003-โ‚น114.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น627.82 1,185.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น493.08 909.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น71.38 46.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,899 5,835.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น93.24 90.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น424.52 769.23%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-โ‚น12.21-125.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น1.88-103.85%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น35.69-26.92%๐Ÿ‡บ๐Ÿ‡ธ USA